AXNX Axonics Modulation Technologies Inc

Price (delayed)

$51.70

Market cap

$2.06B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.96

Enterprise value

$1.82B

Sector: Healthcare
Industry: Medical Devices

Highlights

AXNX's gross profit has surged by 72% since the previous quarter
The revenue has surged by 64% since the previous quarter
AXNX's quick ratio is down by 25% since the previous quarter but it is up by 12% year-on-year
The company's debt rose by 25% YoY

Key stats

What are the main financial stats of AXNX
Market
Shares outstanding
39.81M
Market cap
$2.06B
Enterprise value
$1.82B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.95
Price to sales (P/S)
23.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.99
Earnings
Revenue
$86.7M
EBIT
-$64.33M
EBITDA
-$62.76M
Free cash flow
-$85.86M
Per share
EPS
-$1.96
Free cash flow per share
-$2.21
Book value per share
$7.44
Revenue per share
$2.23
TBVPS
$8.95
Balance sheet
Total assets
$347.67M
Total liabilities
$53.77M
Debt
$30.87M
Equity
$293.9M
Working capital
$295.64M
Liquidity
Debt to equity
0.11
Current ratio
8.62
Quick ratio
7.39
Net debt/EBITDA
3.8
Margins
EBITDA margin
-72.4%
Gross margin
58.1%
Net margin
-76.5%
Operating margin
-75.6%
Efficiency
Return on assets
-23.4%
Return on equity
-28%
Return on invested capital
-98.5%
Return on capital employed
-20.8%
Return on sales
-74.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AXNX stock price

How has the Axonics Modulation Technologies stock price performed over time
Intraday
-1.99%
1 week
-0.25%
1 month
17.79%
1 year
69.84%
YTD
3.57%
QTD
3.57%

Financial performance

How have Axonics Modulation Technologies's revenue and profit performed over time
Revenue
$86.7M
Gross profit
$50.37M
Operating income
-$65.54M
Net income
-$66.32M
Gross margin
58.1%
Net margin
-76.5%
The operating margin has surged by 95% year-on-year and by 51% since the previous quarter
The company's net margin has surged by 95% YoY and by 51% QoQ
AXNX's gross profit has surged by 72% since the previous quarter
The revenue has surged by 64% since the previous quarter

Growth

What is Axonics Modulation Technologies's growth rate over time

Valuation

What is Axonics Modulation Technologies stock price valuation
P/E
N/A
P/B
6.95
P/S
23.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
20.99
AXNX's EPS is up by 25% since the previous quarter
The P/B is 36% above the last 4 quarters average of 5.1
The revenue has surged by 64% since the previous quarter
The price to sales (P/S) is 27% lower than the last 4 quarters average of 31.6

Efficiency

How efficient is Axonics Modulation Technologies business performance
AXNX's ROS has soared by 95% year-on-year and by 51% since the previous quarter
The ROE has increased by 50% YoY and by 37% from the previous quarter
AXNX's ROA is up by 47% YoY and by 35% from the previous quarter
AXNX's ROIC is up by 23% QoQ but it is down by 20% YoY

Dividends

What is AXNX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AXNX.

Financial health

How did Axonics Modulation Technologies financials performed over time
The total liabilities has surged by 59% year-on-year and by 6% since the previous quarter
AXNX's quick ratio is down by 25% since the previous quarter but it is up by 12% year-on-year
The company's debt is 89% lower than its equity
AXNX's debt to equity has dropped by 59% year-on-year but it is up by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.